H
Hongtao Zhang
Researcher at Capital Medical University
Publications - 10
Citations - 572
Hongtao Zhang is an academic researcher from Capital Medical University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 2, co-authored 3 publications receiving 521 citations.
Papers
More filters
Journal ArticleDOI
National Survey of Drug-Resistant Tuberculosis in China
Yanlin Zhao,Shaofa Xu,Lixia Wang,Daniel P. Chin,Shengfen Wang,Guanglu Jiang,Hui Xia,Yang Zhou,Qiang Li,Xichao Ou,Yu Pang,Yuanyuan Song,Bing Zhao,Hongtao Zhang,Guangxue He,Jing Guo,Yu Wang +16 more
TL;DR: China has a serious epidemic of drug-resistant tuberculosis, linked to inadequate treatment in both the public health system and the hospital system, especially tuberculosis hospitals; however, primary transmission accounts for most cases.
Journal ArticleDOI
Rifampin Stability in 7H9 Broth and Löwenstein-Jensen Medium
Xia Yu,Guanglu Jiang,Hui-wen Li,Yan-lin Zhao,Hongtao Zhang,Liping Zhao,Yu Ma,Chris Coulter,Hairong Huang +8 more
TL;DR: Monitoring the stability of rifampin (RIF) in Löwenstein-Jensen medium (L-J medium) and 7H9 broth, which are the media commonly used for drug susceptibility testing (DST) of Mycobacterium tuberculosis, found it to be stable for at least 3 months at a reduced storage temperature.
Journal ArticleDOI
A Peptidomic Approach to Identify Novel Antigen Biomarkers for the Diagnosis of Tuberculosis
Hongmei Chen,Shanshan Li,Weijie Zhao,Jiaheng Deng,Zhuohong Yan,Tingting Zhang,Shu’an Wen,Haiping Guo,Lei Li,J. Yuan,Hongtao Zhang,Liping Ma,Jianhua Zheng,Mengqiu Gao,Yu Pang +14 more
TL;DR: An effective approach to identify new antigen biomarkers via LC-MS/MS-based peptidomics is developed and multiple peptides exhibit promising efficacy in diagnosis of active TB patients.
Patent
Ribonucleoprotein expression vector and construction and application thereof
TL;DR: The ribonucleoprotein expression vector is a ribonuclear protein expression vector constructed using a foreign gene for protein expression, executing the post-translational modification and maintaining a protein natural structure as mentioned in this paper.
Journal ArticleDOI
[Research Progress of Immunotherapy Biomarkers for Non-small Cell Lung Cancer].
TL;DR: The author reviews the biomarkers that have potential to better predict responders to immunotherapy and to provide ideas for the clinical application of immunotherapy.